New concepts in the invasive and non invasive evaluation of remodelling of the right ventricle and pulmonary vasculature in pulmonary arterial hypertension

Open Respiratory Medicine Journal

Volumn 3, Issue , 2009, Pages 31-37

  Domingo, Enric ^a,b   Aguilar, Rio ^a   López Meseguer, Manuel ^a   Teixidó, Gisela ^a   Vazquez, Manuel ^a   Roman, Antonio ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; DOPPLER ECHOGRAPHY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; TISSUE DOPPLER IMAGING;

EID: 77953406139     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306400903010031     Document Type: Article

References (45)

1. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.
2. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.
3. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30: 104-9.
4. Peacock AJ. Primary pulmonary hypertension. Thorax 1999; 54: 1107-18.
5. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-36.
6. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM . Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 13S-24S.
7. Meyrick B, Reid L. Hypoxia and incorporation of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am J Pathol 1979; 96: 51-70.
8. Meyrick B, Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 1980; 100: 151-78.
9. Meyrick B, Reid L. Pulmonary hypertension. Anatomic and physiologic correlates. Clin Chest Med 1983; 4: 199-217.
10. Reid L, Meyrick B. Hypoxia and pulmonary vascular endothelium. Ciba Found Symp 1980; 78: 37-60.
11. Ismail S, Sturrock A, Wu P, Cahill B, Norman K, Huecksteadt TP. NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of TGF-{beta}1 and IGFBP-3. Am J Physiol Lung Cell Mol Physiol 2008 [Epub ahead of print].
12. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1-L8.
13. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-44.
14. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998; 101: 927-34.
15. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-21.
16. Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 2006; 129: 696-705.
17. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155: 411-19.
18. Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta [1] and bone morphogenetic proteins. Circulation 2001; 104: 790-5.
19. Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, Nebigil CG . Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 2002; 8: 1129-35.
20. Mitani Y, Ueda M, Komatsu R, et al. Vascular smooth muscle cell phenotypes in primary pulmonary hypertension. Eur Respir J 2001; 17: 316-20.
21. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-17.
22. Sniderman AD, Fitchett DH. Vasodilators and pulmonary hypertension: the paradox of therapeutic success and clinical failure. Int J Cardiol 1988; 20: 173-81.
23. Rodes J, Domingo E, Roman A, et al. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart 2003; 89: 311-16.
24. Berger RMF, Cromme-Dijkhuis AH, Hop WCJ, et al. Pulmonary arterial distensibility assessed by intravascular ultrasound in children with congenital heart disease. An indicator for pulmonary vascular disease? Chest 2002; 122: 549-57.
25. Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev 1995; 47: 87-131.
26. Mahapatra S, Nishimura RA, Sorajja P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hipertension. J Am Coll Cardiol 2006; 47: 799-803.
27. Milnor WR, Conti CR, Lewis KB, et al. Pulmonary arterial pulse wave velocity and impedance in man. Circ Res 1969; 25: 637-49.
28. Westerhof N, Elcinga G, Sipkema P. An artificial arterial system for pumping hearts. J Appl Physiol 1971; 31: 776-81.
29. Pandian NG. Intracardiac, intravascular, two-dimensional, high-frequency ultrasound imaging of pulmonary artery and its branches in humans and animals. Circulation 1990; 81: 2007-12.
30. Isshii M. Evaluation of pulmonary artery histopathologic findings in congenital heart disease: an in vitro study using intravascular ultrasound imaging. J Am Coll Cardiol 1995; 26: 272-6.
31. Rieber J. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex vivo coronary specimens: a comparison with histology. Coron Artery Dis 2006; 17: 425-30.
32. Regar E, Schaar JA, Mont E, Virmani R, Serruys PW. Optical coherence tomography. Cardiovasc Radiat Med 2003; 4: 198-204.
33. Brezinski ME. Optical coherence tomography for identifying unstable plaque. Int J Cardiol 2006; 107: 154-65.
34. Brimioulle S, Wauthy P, Ewalenko P, et al. Single beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284: 1625-30.
35. Imanishi T, Nakatani S, Yamada S, et al. Validation of continous wave Doppler determined right ventricular peak positive and negative dP/dT. J Am Coll Cardiol 1994; 23: 1638-43.
36. Naeije R, Torbicki A. More on non invasive diagnosis of pulmonary hypertension. Eur Resp J 1995; 8: 1445-9.
37. Raymond RJ, Hinderlitter AL, Willis PV, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002; 39: 1214-19.
38. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report of the American Society of Echocardiography's guidelines. J Am Soc Echocardiogr 2005; 18: 1440-63.
39. Ueti OM, Camargo EE, Ueti Ade A, et al. Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion. Heart 2002; 88: 244-8.
40. Endo Y, Maddukuri PV, Vieira ML, et al. Quantification of right ventricular volumes by real time three dimensional echocardiographic longitudinal axial plane method: validation in the clinical setting. Echocardiography 2006; 23: 853-9.
41. Lopez-Candales A, Rajagopalan N, Saxena N, et al. Right ventricular systolic function is not the sole determinant of tricuspid annular motion. Am J Cardiol 2006; 98: 973-7.
42. Lopez- Candales A, Rjagopalan N, Dohi K, et al. Normal range of mechanical variables in pulmonary hypertension Doppler imaging study. Echocardiography 2008; 25: 864-72.
43. Schwartz DL, Kop WJ, Park MH, et al. Evidence of right ventricular and septal mechanical activation [interventricular dyssynchrony ] in pulmonary hypertension. Am J Cardiol 2009; 102: 1273-7.
44. Shiina Y, Funabashi N, Lee K, et al. Right atrium contractility and right ventricular diastolic function: tissue Doppler imaging can predict brain natriuretic peptide in acquired pulmonary hypertension. Int J Cardiol 2008; 3: 90.
45. Huez S, Vachiery JL, Unger P, et al. Tissue Doppler imaging evaluation of cardiac adaptation to severe pulmonary hypertension. Am J Cardiol 2007; 100: 1473-8.